This page provides federal resources that are helpful during emergencies and disasters. We also created Medicaid & CHIP disaster preparedness toolkits to provide states and territories with additional disaster-related information.
Federal Disaster Resources
On August 8, 2023, the President of the United States issued a proclamation that 2023 Hawaii Wildfires constitutes an emergency by the authorities vested in the President by the Constitution and the laws of the United States, including sections 201 and 301 of the National Emergencies Act (50 U.S.C. 1601 et seq.), and consistent with section 1135 of the Social Security Act (the Act).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Idaho for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on July 8, 2022, detailed an additional federal requirement that also poses issues or challenges for the health care delivery system in Idaho and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Utah for multiple section 1135 flexibilities on April 10, 2020. Your follow-up communication to CMS on October 28, 2021, requests section 1135 flexibilities for state plan amendment (SPA), UT-21-0010.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Vermont for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on October 6, 2021 detailed additional federal requirements that also pose issues or challenges for the health care delivery system in Vermont and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Arkansas for multiple section 1135 flexibilities on April 2, 2020. Your follow-up communication to CMS on September 14, 2021, detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Arkansas and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Kansas for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on July 14, 2021 detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Kansas and requested a waiver or modification of those additional requirements.
On March 13, 2020, the President of the United States issued a proclamation that the COVID-19 outbreak in the United States constitutes a national emergency by the authorities vested in him by the Constitution and the laws of the United States, including sections 201 and 301 of the National Emergencies Act (50 U.S.C. 1601 et seq.), and consistent with section 1135 of the Act.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Colorado for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on February 19, 2021 detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Colorado and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maine for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on February 17, 2021 detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Maine and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Tennessee for multiple section 1135 flexibilities on March 31, 2020. Your follow-up communication to CMS on March 29, 2021 indicated Tennessee’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Texas for multiple section 1135 flexibilities on March 30, 2020 and subsequently on May 22, 2020, July 23, 2020 and September 30, 2020. Your initial request submitted to CMS on March 25, 2020 detailed two federal requirements that pose issues or challenges for the health care delivery system in Texas that CMS initially approved on November 25, 2020.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Nevada for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on December 15, 2020 detailed additional federal requirements that also pose issues or challenges for the health care delivery system in Nevada that CMS initially approved on December 18, 2020.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Kentucky for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on December 17, 2020 detailed additional federal requirements that also pose issues or challenges for the health care delivery system in Kentucky.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Arkansas for multiple section 1135 flexibilities on March 23, 2020. The COVID-19 pandemic has created delays with the submission of coverage and payment State Plan Amendments (SPAs) in alignment with regulatory SPA submission and notice timelines.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of South Dakota for multiple section 1135 flexibilities on March 24, 2020. Your follow-up communication to CMS on January11, 2021, indicated South Dakota’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Hawaii for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 27, 2021 indicated Hawaii’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Georgia for multiple section 1135 flexibilities on April 1, 2020. Your follow-up communication to CMS on January 12, 2021 indicated Georgia’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Oregon for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 12, 2021 indicated Oregon’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New York for multiple section 1135 flexibilities on March 26, 2020. Your Disaster Relief SPA submission, Transmittal Number 20-0048, submitted on August 25, 2020, and follow-up communication on October 7, 2020, detailed an additional federal requirement that also poses issues or challenges for the health care delivery system in New York and requested a modification of an additional requirement.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New York for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 12, 2021, indicated New York’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Wyoming for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Wyoming’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Oklahoma for multiple section 1135 flexibilities on March 24, 2020. Your follow-up communication to CMS on January 19, 2021 detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Oklahoma and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Nebraska for multiple section 1135 flexibilities on April 2, 2020. Your follow-up communication to CMS on January 14, 2021, indicated Nebraska’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Kansas for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 7, 2021, indicated Kansas’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Colorado for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 12, 2021, indicated Colorado’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Arizona for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communications to CMS on February 12, 2021 and March 16, 2021 indicated Arizona’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Vermont for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Vermont’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of South Carolina for multiple section 1135 flexibilities on March 31, 2020. Your follow-up communication to CMS on January 14, 2021 indicated South Carolina’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Nevada for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on January 12, 2021 indicated Nevada’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Missouri for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 11, 2021 indicated Missouri’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Missouri for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on February 16, 2021, detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Missouri and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Minnesota for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on February 10, 2021, indicated Minnesota’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maine for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on February 12, 2021 indicated Maine’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Louisiana for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 19, 2021 indicated Louisiana’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Idaho for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 7, 2021, indicated Idaho’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Iowa for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 12, 2021, indicated Iowa’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Florida for multiple section 1135 flexibilities on March 16, 2020. Your follow-up communication to CMS on February 9, 2021 indicated Florida’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Ohio for multiple section 1135 flexibilities on April 22, 2020. Your follow-up communication to CMS on January 12, 2021 indicated Ohio’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maryland for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Maryland’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Delaware for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Delaware’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Alabama for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Alabama’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Massachusetts for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Massachusetts’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Montana for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021, indicated Montana’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Connecticut for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Connecticut’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New Mexico for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 14, 2021 indicated New Mexico’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New Hampshire for multiple section 1135 flexibilities on March 23, 2020 Your follow-up communication to CMS on January 12, 2021 indicated New Hampshire’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of North Carolina for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 14, 2021 indicated North Carolina’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the Commonwealth of Puerto Rico for multiple section 1135 flexibilities on April 14, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Puerto Rico’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Rhode Island for multiple section 1135 flexibilities on March 25, 2020 and subsequent approvals on May 18, 2020. Your follow-up communication to CMS on February 9, 2021 detailed additional federal requirements that also pose issues or challenges for the health care delivery system in Rhode Island and requested a waiver or modification of those additional requirements.
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Rhode Island for multiple section 1135 flexibilities on March 25, 2020 Your follow-up communication to CMS on January 13, 2021 indicated Rhode Island’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Show
entries